Chorionic Gonadotrophin Market

Human chorionic gonadotropin (HCG), a polypeptide hormone produced by the human placenta. Endogenously produced HCG interacts with the LHCG receptor of the ovary and promotes the maintenance of the corpus luteum during the beginning of pregnancy. This allows the corpus luteum to continuously secrete the hormone progesterone during the first trimester, which is required for maintenance of the uterus and prevents menstruation. In males, HCG also stimulates the production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of the testis to produce androgens.

Chorionic Gonadotrophin Market contains market size and forecasts of Chorionic Gonadotrophin in global, including the following market information:

Global Chorionic Gonadotrophin Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Chorionic Gonadotrophin Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Chorionic Gonadotrophin companies in 2021 (%)

The global Chorionic Gonadotrophin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

500U Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chorionic Gonadotrophin include Merck Serono, Bristol Myers Squibb, Ferring, Fresenius Kabi, Sun Pharmaceutical, Besins Healthcare Benelux, Jean-Marie, Organon and Hubei Dongxin Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Chorionic Gonadotrophin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chorionic Gonadotrophin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Chorionic Gonadotrophin Market Segment Percentages, by Type, 2021 (%)

500U

1000U

2000U

3000U

5000U

Global Chorionic Gonadotrophin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Chorionic Gonadotrophin Market Segment Percentages, by Application, 2021 (%)

Undescended Testicles In Adolescence

Male Infertility

Female Anovulatory Infertility

In Vitro Fertilization

Abortion

Functional Uterine Hemorrhage

Other

Global Chorionic Gonadotrophin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Chorionic Gonadotrophin Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chorionic Gonadotrophin revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Chorionic Gonadotrophin revenues share in global market, 2021 (%)

Key companies Chorionic Gonadotrophin sales in global market, 2017-2022 (Estimated), (KG)

Key companies Chorionic Gonadotrophin sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Merck Serono

Bristol Myers Squibb

Ferring

Fresenius Kabi

Sun Pharmaceutical

Besins Healthcare Benelux

Jean-Marie

Organon

Hubei Dongxin Pharmaceutical

Changchun Jinsai Pharmaceutical

Ningbo Renjian Pharmaceutical Group

Yantai Dongcheng North Pharmaceutical

Maanshan Fengyuan Pharmaceutical

Sinopharm

Livzon Pharmaceutical Group

Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)